Clinical Trial Update: Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated adding lapatinib to chemoradiation in patients with locally advanced laryngeal or hypopharyngeal cancer. The study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hypopharyngeal Cancer
• Laryngeal Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED